Increased turnover of CCR5+ and redistribution of CCR5- CD4 T lymphocytes during primary human immunodeficiency virus type 1 infection

J Infect Dis. 2001 Mar 1;183(5):736-43. doi: 10.1086/318827. Epub 2001 Feb 1.

Abstract

CCR5 is the major coreceptor for human immunodeficiency virus (HIV) type 1 during primary infection. CCR5+ CD4 T lymphocytes were studied in subjects with primary HIV-1 infection (PHI) or acute Epstein-Barr virus (EBV) infection and in HIV-uninfected controls. The early decline of CD4 T lymphocytes during PHI resulted from depletion of CCR5- CD4 T lymphocytes. After antiretroviral therapy, Ki-67- CCR5- CD4 T cell counts rapidly increased in the circulation, which suggests that the initial decrease was due to an alteration in trafficking and/or sequestration. In the CCR5+ subset of CD4 T cells, there was an elevation in the proliferative (Ki-67+) fraction during PHI, yet their total number remained in the normal range. In contrast, in acute EBV infection, proliferating CCR5+ CD4 T cells accumulated to very high levels, suggesting they have an important role in the early antiviral response, which may be impaired in HIV-1 infection.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-HIV Agents / pharmacology
  • Anti-HIV Agents / therapeutic use*
  • CD4 Lymphocyte Count
  • CD4-Positive T-Lymphocytes / drug effects
  • CD4-Positive T-Lymphocytes / immunology
  • CD4-Positive T-Lymphocytes / metabolism*
  • Carbamates
  • Dideoxynucleosides / pharmacology
  • Dideoxynucleosides / therapeutic use
  • Epstein-Barr Virus Infections / immunology
  • Flow Cytometry
  • Furans
  • Genotype
  • HIV Infections / drug therapy
  • HIV Infections / immunology*
  • HIV-1 / drug effects
  • HIV-1 / genetics
  • HIV-1 / immunology*
  • Humans
  • Immunoglobulin M / blood
  • Lamivudine / pharmacology
  • Lamivudine / therapeutic use
  • Longitudinal Studies
  • Male
  • Proto-Oncogene Proteins c-bcl-2 / biosynthesis
  • Receptors, CCR5 / biosynthesis*
  • Receptors, CCR5 / genetics
  • Receptors, CCR5 / immunology
  • Sulfonamides / pharmacology
  • Sulfonamides / therapeutic use
  • Time Factors
  • Zidovudine / pharmacology
  • Zidovudine / therapeutic use

Substances

  • Anti-HIV Agents
  • Carbamates
  • Dideoxynucleosides
  • Furans
  • Immunoglobulin M
  • Proto-Oncogene Proteins c-bcl-2
  • Receptors, CCR5
  • Sulfonamides
  • Lamivudine
  • Zidovudine
  • amprenavir
  • abacavir